Jianshi Technology focuses on R&D, production, sales and service in the field of minimally invasive valve interventional therapy, and strives to provide innovative solutions for doctors and patients. The company is committed to becoming a world-class technology leader in cardiac valve interventional therapy. Jianshi Technology is listed in Hong Kong today. It opened slightly higher at HK$28 in morning trading. According to the previous placement results, the company’s offering price was set at HK$27.8 per share. As of 10:10 a.m., the company’s stock price was HK$28.55, an increase of 2.7%, with a total market value of HK$11.9 billion.
This article is reproduced from: https://www.itjuzi.com/investevent/13593048
This site is for inclusion only, and the copyright belongs to the original author.